Abstract
A number of systemic autoimmune diseases are associated with increased levels of the agalactosyl (G(0)) IgG isoforms that lack a terminal galactose from the C(H)2 domain oligosaccharide. The current aim was to determine whether the galactosylation of serum IgG is also reduced in a classic antibody-mediated, organ-specific autoimmune condition, and whether the pathogenic autoantibodies are preferentially G(0). In two murine forms of autoimmune haemolytic anaemia (AIHA), sera and autoantibodies eluted from erythrocytes were obtained, and the levels of G(0) measured using a lectin-binding assay. Serum IgG galactosylation was unaffected following the induction of AIHA in CBA/Ig(b) mice by immunization with rat erythrocytes, but in all animals with the disease the IgG autoantibodies generated were more G(0) than the sera. The anti-rat erythrocyte antibodies were similar to the autoantibodies in being preferentially G(0), and when CBA/Ig(b) mice were immunized with canine erythrocytes as a control foreign antigen, there was again a bias towards the production of G(0) IgG antibodies. In NZB mice with chronic, spontaneous AIHA, the concentration and galactosylation of both serum IgG and autoantibodies were lower than in the induced model, and the ratio of G(0) IgG in the serum and erythrocyte eluates varied markedly between different individuals. Our interpretation of these results is that changes in serum IgG or autoantibody galactosylation are not consistent in different models of AIHA, and that production of low galactosyl antibodies can be a feature of a normal immune response.
Original language | English |
---|---|
Pages (from-to) | 449-454 |
Number of pages | 6 |
Journal | Clinical and Experimental Immunology |
Volume | 117 |
Publication status | Published - 1999 |
Keywords
- agalactosyl IgG
- autoantibody
- erythrocyte
- autoimmune haemolytic anaemia
- NZB mouse
- PRISTANE-INDUCED ARTHRITIS
- RED-CELL AUTOANTIBODIES
- AGALACTOSYL IGG
- RHEUMATOID-ARTHRITIS
- NORMAL MICE
- GLYCOSYLATION
- TUBERCULOSIS
- COMPLEMENT
- HEMOLYSIS
- RESPONSES